Skip to main content
. 2021 Jan 13;11:1199. doi: 10.1038/s41598-020-79801-1

Table 3.

The expression of HIF-1α in NSCLC tissues before receiving EGFR-TKIs treatment and after gaining EGFR-TKIs acquired resistance for patients receiving a second biopsy.

Group HIF-1α expression score Median (P25th, P75th) P value
Before EGFR-TKIs treatment After EGFR-TKIs acquired resistance
Second biopsy group (n = 41) 6 (3, 8.5) 8 (6, 10.5) 0.000
T790M mutation group (n = 20) 5.5 (2.25, 8.5) 7.5 (5.25, 9.75) 0.012
Without T790M mutation (n = 21) 7 (3, 8.5) 9 (8, 11) 0.001